# GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma

> **NCT05352542** · PHASE1 · TERMINATED · sponsor: **jianming xu** · enrollment: 10 (actual)

## Conditions studied

- Advanced Hepatocellular Carcinoma

## Interventions

- **BIOLOGICAL:** GPC3 Targeting CART Cells

## Key facts

- **NCT ID:** NCT05352542
- **Lead sponsor:** jianming xu
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-19
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** achieve the proof of concept
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05352542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05352542, "GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05352542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*